111 related articles for article (PubMed ID: 31853714)
1. Impact of body mass index, smoking habit, alcohol consumption, physical activity and parity on disease course of women with triple-negative breast cancer.
Schmidt G; Schneider C; Gerlinger C; Endrikat J; Gabriel L; Ströder R; Müller C; Juhasz-Böss I; Solomayer EF
Arch Gynecol Obstet; 2020 Feb; 301(2):603-609. PubMed ID: 31853714
[TBL] [Abstract][Full Text] [Related]
2. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
Lara-Medina F; Pérez-Sánchez V; Saavedra-Pérez D; Blake-Cerda M; Arce C; Motola-Kuba D; Villarreal-Garza C; González-Angulo AM; Bargalló E; Aguilar JL; Mohar A; Arrieta Ó
Cancer; 2011 Aug; 117(16):3658-69. PubMed ID: 21387260
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, diabetes, and triple-negative breast cancer prognosis.
Tait S; Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
Breast Cancer Res Treat; 2014 Jul; 146(1):189-97. PubMed ID: 24869799
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.
Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L
Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying social inequality in post-menopausal breast cancer.
Hvidtfeldt UA
Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
[TBL] [Abstract][Full Text] [Related]
8. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and weight change in relation to triple-negative breast cancer survival.
Bao PP; Cai H; Peng P; Gu K; Su Y; Shu XO; Zheng Y
Cancer Causes Control; 2016 Feb; 27(2):229-36. PubMed ID: 26621544
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
11. High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy.
Na H; Han J; Ka NL; Lee MH; Choi YL; Shin YK; Lee MO
Breast Cancer Res; 2019 Nov; 21(1):127. PubMed ID: 31779659
[TBL] [Abstract][Full Text] [Related]
12. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort.
D'Aiuto M; Chirico A; De Riggi MA; Frasci G; De Laurentiis M; Di Bonito M; Vici P; Pizzuti L; Sergi D; Maugeri-Saccà M; Barba M; Giordano A
Cancer Biol Ther; 2016 May; 17(5):470-6. PubMed ID: 26934127
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
Bignon L; Fricker JP; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Caron O; Lortholary A; Faivre L; Lasset C; Mari V; Gesta P; Gladieff L; Hamimi A; Petit T; Velten M
Breast J; 2018 May; 24(3):269-277. PubMed ID: 28929593
[TBL] [Abstract][Full Text] [Related]
15. Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
Liu YL; Saraf A; Catanese B; Lee SM; Zhang Y; Connolly EP; Kalinsky K
Breast Cancer Res Treat; 2018 Jan; 167(1):277-288. PubMed ID: 28948418
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
17. Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study.
Hellmann SS; Thygesen LC; Tolstrup JS; Grønbaek M
Eur J Cancer Prev; 2010 Sep; 19(5):366-73. PubMed ID: 20502344
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
Gamucci T; Pizzuti L; Sperduti I; Mentuccia L; Vaccaro A; Moscetti L; Marchetti P; Carbognin L; Michelotti A; Iezzi L; Cassano A; Grassadonia A; Astone A; Botticelli A; Magnolfi E; Di Lauro L; Sergi D; Fuso P; Tinari N; Barba M; Maugeri-Saccà M; Landucci E; Conti F; Sanguineti G; De Tursi M; Iafrate G; Giordano A; Ciliberto G; Natoli C; Vici P
J Cell Physiol; 2018 Mar; 233(3):2313-2323. PubMed ID: 28710865
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
Kennard K; Buckley ME; Sizer LM; Larson S; Carter WB; Frazier TG; Carp NZ
Breast Cancer Res Treat; 2021 Feb; 186(1):53-63. PubMed ID: 33389405
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC.
Biswas T; Efird JT; Prasad S; James SE; Walker PR; Zagar TM
Clin Breast Cancer; 2016 Jun; 16(3):212-6. PubMed ID: 26988771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
